These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 22075104)

  • 1. Performance improvement CME: managing schizophrenia.
    Kane JM; Correll CU
    J Clin Psychiatry; 2011 Oct; 72(10):e31. PubMed ID: 22075104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relapse prevention and recovery in the treatment of schizophrenia.
    Schooler NR
    J Clin Psychiatry; 2006; 67 Suppl 5():19-23. PubMed ID: 16822093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptomatic presentation and initial treatment for schizophrenia in children and adolescents.
    Correll CU
    J Clin Psychiatry; 2010 Nov; 71(11):e29. PubMed ID: 21114942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia.
    Leucht S; Heres S
    J Clin Psychiatry; 2006; 67 Suppl 5():3-8. PubMed ID: 16822090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The new approach: psychosocial functioning as a necessary outcome criterion for therapeutic success in schizophrenia.
    Juckel G; Morosini PL
    Curr Opin Psychiatry; 2008 Nov; 21(6):630-9. PubMed ID: 18852573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of schizophrenia.
    Marder SR
    J Clin Psychiatry; 1996; 57 Suppl 3():9-13; discussion 47. PubMed ID: 8626371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and effectiveness of individual family intervention on social and clinical functioning and family burden in severe schizophrenia: a 2-year randomized controlled study.
    Girón M; Fernández-Yañez A; Mañá-Alvarenga S; Molina-Habas A; Nolasco A; Gómez-Beneyto M
    Psychol Med; 2010 Jan; 40(1):73-84. PubMed ID: 19490746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of the combination of psychosocial and pharmacological treatment in schizophrenic patients].
    Valencia Collazos M; Ortega Soto HA; Rascón Gasca ML; Gómez Caudillo L
    Actas Esp Psiquiatr; 2002; 30(6):358-69. PubMed ID: 12487946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interventions to improve antipsychotic medication adherence: review of recent literature.
    Dolder CR; Lacro JP; Leckband S; Jeste DV
    J Clin Psychopharmacol; 2003 Aug; 23(4):389-99. PubMed ID: 12920416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.
    Velligan DI; Weiden PJ; Sajatovic M; Scott J; Carpenter D; Ross R; Docherty JP;
    J Clin Psychiatry; 2009; 70 Suppl 4():1-46; quiz 47-8. PubMed ID: 19686636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risperidone long-acting injection (RLAI): the 12-week efficacy and tolerability in Thai patients with chronic schizophrenia.
    Arunpongpaisal S; Srisurapanont M; Kongsakon R; Kitiwattanagul K; Samanwongthai U
    J Med Assoc Thai; 2010 Mar; 93(3):343-50. PubMed ID: 20420110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia.
    Novick D; Haro JM; Suarez D; Perez V; Dittmann RW; Haddad PM
    Psychiatry Res; 2010 Apr; 176(2-3):109-13. PubMed ID: 20185182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maintenance therapy of persons with schizophrenia.
    Carpenter WT
    J Clin Psychiatry; 1996; 57 Suppl 9():10-8. PubMed ID: 8823345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status of family intervention science.
    Diamond G; Siqueland L
    Child Adolesc Psychiatr Clin N Am; 2001 Jul; 10(3):641-61. PubMed ID: 11449817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment retention with risperidone long-acting injection: 24-month results from the Electronic Schizophrenia Treatment Adherence Registry (e-STAR) in six countries.
    Peuskens J; Olivares JM; Pecenak J; Tuma I; Bij de Weg H; Eriksson L; Resseler S; Akhras K; Jacobs A
    Curr Med Res Opin; 2010 Mar; 26(3):501-9. PubMed ID: 20014981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized controlled trial of interventions for young people at ultra high risk for psychosis: 6-month analysis.
    Yung AR; Phillips LJ; Nelson B; Francey SM; PanYuen H; Simmons MB; Ross ML; Kelly D; Baker K; Amminger GP; Berger G; Thompson AD; Thampi A; McGorry PD
    J Clin Psychiatry; 2011 Apr; 72(4):430-40. PubMed ID: 21034687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive behavioral therapy for schizophrenia.
    Rathod S; Phiri P; Kingdon D
    Psychiatr Clin North Am; 2010 Sep; 33(3):527-36. PubMed ID: 20599131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical effectiveness of new generation antipsychotics in adolescent patients.
    Arango C; Parellada M; Moreno DM
    Eur Neuropsychopharmacol; 2004 Nov; 14 Suppl 4():S471-9. PubMed ID: 15572266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An RCT of adherence therapy for people with schizophrenia in Chiang Mai, Thailand.
    Maneesakorn S; Robson D; Gournay K; Gray R
    J Clin Nurs; 2007 Jul; 16(7):1302-12. PubMed ID: 17584349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.